Ocular Historical Financial Ratios

OCUL Stock  USD 7.14  0.20  2.88%   
Ocular Therapeutix is promptly reporting on over 107 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 294 will help investors to properly organize and evaluate Ocular Therapeutix financial condition quickly.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocular Therapeutix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.

About Ocular Financial Ratios Analysis

Ocular TherapeutixFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Ocular Therapeutix investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Ocular financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Ocular Therapeutix history.

Ocular Therapeutix Financial Ratios Chart

At this time, Ocular Therapeutix's Payables Turnover is quite stable compared to the past year. Cash Per Share is expected to rise to 3.85 this year, although the value of Free Cash Flow Yield will most likely fall to (0.20).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Ocular Therapeutix stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Ocular Therapeutix sales, a figure that is much harder to manipulate than other Ocular Therapeutix multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.
Most ratios from Ocular Therapeutix's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Ocular Therapeutix current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocular Therapeutix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.At this time, Ocular Therapeutix's Payables Turnover is quite stable compared to the past year. Cash Per Share is expected to rise to 3.85 this year, although the value of Free Cash Flow Yield will most likely fall to (0.20).
 2022 2023 2024 2025 (projected)
Payables Turnover0.891.21.382.26
Days Of Inventory On Hand158.7159.31183.21201.23

Ocular Therapeutix fundamentals Correlations

-0.040.99-0.77-0.3-0.83-0.43-0.041.0-0.820.06-0.62-0.810.74-0.150.990.810.27-0.650.460.261.0-0.13-0.050.330.19
-0.04-0.060.10.560.160.151.0-0.040.160.590.010.090.01-0.02-0.040.13-0.430.01-0.18-0.42-0.030.08-0.97-0.38-0.18
0.99-0.06-0.75-0.27-0.78-0.48-0.060.98-0.770.1-0.62-0.760.71-0.170.970.780.23-0.540.470.210.98-0.1-0.010.30.16
-0.770.1-0.750.450.930.470.1-0.780.920.090.650.85-0.77-0.49-0.76-0.69-0.380.6-0.46-0.36-0.710.110.0-0.44-0.22
-0.30.56-0.270.450.45-0.140.56-0.30.470.810.030.34-0.11-0.14-0.370.07-0.790.50.14-0.78-0.30.25-0.42-0.77-0.43
-0.830.16-0.780.930.450.350.16-0.861.00.150.690.95-0.86-0.36-0.83-0.81-0.370.78-0.45-0.35-0.80.19-0.04-0.4-0.28
-0.430.15-0.480.47-0.140.350.15-0.420.31-0.230.50.34-0.4-0.13-0.33-0.370.170.04-0.930.2-0.38-0.23-0.210.120.22
-0.041.0-0.060.10.560.160.15-0.040.160.590.010.090.01-0.02-0.040.13-0.430.01-0.18-0.42-0.030.08-0.97-0.38-0.18
1.0-0.040.98-0.78-0.3-0.86-0.42-0.04-0.850.06-0.65-0.830.77-0.110.990.830.26-0.670.470.250.99-0.14-0.050.320.2
-0.820.16-0.770.920.471.00.310.16-0.850.170.670.95-0.86-0.36-0.83-0.81-0.380.79-0.41-0.36-0.790.2-0.04-0.41-0.29
0.060.590.10.090.810.15-0.230.590.060.17-0.360.060.2-0.07-0.020.37-0.530.370.15-0.520.05-0.08-0.53-0.47-0.06
-0.620.01-0.620.650.030.690.50.01-0.650.67-0.360.73-0.91-0.29-0.57-0.820.030.34-0.470.04-0.60.360.03-0.02-0.35
-0.810.09-0.760.850.340.950.340.09-0.830.950.060.73-0.87-0.29-0.81-0.84-0.130.75-0.45-0.12-0.780.37-0.01-0.17-0.41
0.740.010.71-0.77-0.11-0.86-0.40.010.77-0.860.2-0.91-0.870.320.710.920.08-0.570.450.070.72-0.23-0.080.130.24
-0.15-0.02-0.17-0.49-0.14-0.36-0.13-0.02-0.11-0.36-0.07-0.29-0.290.32-0.170.140.13-0.060.10.13-0.22-0.03-0.020.150.07
0.99-0.040.97-0.76-0.37-0.83-0.33-0.040.99-0.83-0.02-0.57-0.810.71-0.170.770.31-0.70.380.30.99-0.14-0.060.370.22
0.810.130.78-0.690.07-0.81-0.370.130.83-0.810.37-0.82-0.840.920.140.77-0.02-0.550.45-0.030.8-0.19-0.190.030.17
0.27-0.430.23-0.38-0.79-0.370.17-0.430.26-0.38-0.530.03-0.130.080.130.31-0.02-0.4-0.181.00.27-0.050.230.990.25
-0.650.01-0.540.60.50.780.040.01-0.670.790.370.340.75-0.57-0.06-0.7-0.55-0.4-0.23-0.39-0.670.220.12-0.39-0.3
0.46-0.180.47-0.460.14-0.45-0.93-0.180.47-0.410.15-0.47-0.450.450.10.380.45-0.18-0.23-0.20.430.210.23-0.16-0.22
0.26-0.420.21-0.36-0.78-0.350.2-0.420.25-0.36-0.520.04-0.120.070.130.3-0.031.0-0.39-0.20.25-0.050.220.990.25
1.0-0.030.98-0.71-0.3-0.8-0.38-0.030.99-0.790.05-0.6-0.780.72-0.220.990.80.27-0.670.430.25-0.13-0.060.320.2
-0.130.08-0.10.110.250.19-0.230.08-0.140.2-0.080.360.37-0.23-0.03-0.14-0.19-0.050.220.21-0.05-0.13-0.03-0.03-0.98
-0.05-0.97-0.010.0-0.42-0.04-0.21-0.97-0.05-0.04-0.530.03-0.01-0.08-0.02-0.06-0.190.230.120.230.22-0.06-0.030.180.09
0.33-0.380.3-0.44-0.77-0.40.12-0.380.32-0.41-0.47-0.02-0.170.130.150.370.030.99-0.39-0.160.990.32-0.030.180.24
0.19-0.180.16-0.22-0.43-0.280.22-0.180.2-0.29-0.06-0.35-0.410.240.070.220.170.25-0.3-0.220.250.2-0.980.090.24
Click cells to compare fundamentals

Ocular Therapeutix Account Relationship Matchups

Ocular Therapeutix fundamentals Accounts

202020212022202320242025 (projected)
Price To Sales Ratio72.2612.234.26.097.016.66
Ptb Ratio16.536.056.113.913.523.69
Days Sales Outstanding256.97177.25151.16163.5188.02293.54
Book Value Per Share1.251.150.461.141.031.08
Free Cash Flow Yield(0.0433)(0.13)(0.29)(0.21)(0.19)(0.2)
Operating Cash Flow Per Share(1.71)(0.88)(0.86)(0.78)(0.79)(0.83)
Stock Based Compensation To Revenue2.070.430.340.330.30.35
Capex To Depreciation0.30.491.762.042.351.8
Pb Ratio16.536.056.113.913.523.69
Ev To Sales62.529.823.464.174.794.55
Free Cash Flow Per Share(1.76)(0.9)(0.87)(0.82)(0.96)(0.86)
Roic(0.26)(0.71)(0.58)(0.38)(0.34)(0.36)
Inventory Turnover1.733.522.32.292.062.02
Net Income Per Share(2.63)(0.14)(0.83)(1.01)(0.91)(0.96)
Days Of Inventory On Hand210.45103.55158.7159.31183.21201.23
Payables Turnover0.770.960.891.21.382.26
Sales General And Administrative To Revenue5.231.310.730.630.580.67
Research And Ddevelopement To Revenue9.721.651.151.041.21.14
Capex To Revenue0.04830.02740.07210.10.120.11
Cash Per Share3.752.151.332.452.823.85
Pocfratio(23.48)(8.12)(3.62)(5.07)(5.83)(6.12)
Interest Coverage(9.29)(11.7)(11.2)(7.27)(6.54)(6.87)
Capex To Operating Cash Flow(0.0157)(0.0182)(0.0623)(0.0867)(0.0997)(0.1)
Pfcf Ratio(23.12)(7.98)(3.41)(4.66)(5.36)(5.63)
Days Payables Outstanding474.69380.41411.87303.35348.85331.41
Income Quality0.3410.00.840.870.781.25
Roe(2.1)(0.12)(1.79)(0.89)(0.8)(0.76)
Ev To Operating Cash Flow(20.32)(6.52)(2.99)(3.47)(3.99)(4.19)
Pe Ratio(7.88)(49.28)(3.41)(4.41)(5.07)(5.32)
Return On Tangible Assets(0.61)(0.0527)(0.42)(0.32)(0.29)(0.3)
Ev To Free Cash Flow(20.0)(6.4)(2.81)(3.19)(3.67)(3.85)
Earnings Yield(0.13)(0.0203)(0.29)(0.23)(0.2)(0.21)
Net Debt To E B I T D A1.161.390.611.691.521.6
Current Ratio9.237.264.136.667.658.73
Tangible Book Value Per Share1.251.150.461.141.031.08
Receivables Turnover1.422.062.412.232.574.74
Graham Number8.611.912.925.15.865.57
Shareholders Equity Per Share1.251.150.461.141.031.08
Debt To Equity0.770.671.820.921.051.1
Capex Per Share0.01380.01560.04830.07630.08770.0927

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Ocular Therapeutix is a strong investment it is important to analyze Ocular Therapeutix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocular Therapeutix's future performance. For an informed investment choice regarding Ocular Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocular Therapeutix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocular Therapeutix. If investors know Ocular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocular Therapeutix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Revenue Per Share
0.447
Quarterly Revenue Growth
0.023
Return On Assets
(0.27)
Return On Equity
(0.97)
The market value of Ocular Therapeutix is measured differently than its book value, which is the value of Ocular that is recorded on the company's balance sheet. Investors also form their own opinion of Ocular Therapeutix's value that differs from its market value or its book value, called intrinsic value, which is Ocular Therapeutix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocular Therapeutix's market value can be influenced by many factors that don't directly affect Ocular Therapeutix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocular Therapeutix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocular Therapeutix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocular Therapeutix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.